Bill tracker, H.R. 1492, Health

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

  1. Introduced
  2. In committee
  3. Reported
  4. Passed the House
  5. Passed the Senate
  6. To the President
  7. Became law

Introduced Feb 21, 2025 with 68 cosponsors. Latest action Feb 21, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Sponsor

Committees

Timeline

CommitteeHouseSenatePresidentMarFeb 21, 2025: Introduced in HouseFeb 21, 2025: Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
PassedFailed, tabled or vetoedBecame lawOther steps

What happened to it

Full history

    • ReferredHouse. Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
    • IntroducedIntroduced in House

Subjects

Health care costs and insuranceMedicarePrescription drugs

Read the bill on Congress.gov